Health minister welcomes new treatments for COVID-19 patients
The treatments are being offered as an addition to vaccinations to maximise protection against COVID-19
Read More
Author: Iona Everson
NICE publish final guidance recommending Aspaveli in adults with ultra-rare blood disorder
The drug is additionally undergoing assessment with the Medicines and Healthcare products Regulatory Agency for a marketing authorisation in the UK
Read More
Cancer clinical trial recruitment drops by 60% during pandemic
In a new report from The Institute of Cancer Research (ICR), data from cancer trials alongside assessments from clinicians and patients aims to provide guidance on how to improve services
Read More
Marketing authorisation acquired for first and only transdermal contraceptive patch in UK
The Evra hormonal patch can be worn discreetly and according to Gedeon Richter UK Ltd, is over 99% effective at pregnancy prevention
Read More
WHO says vaccines should be effective against Omicron variant
A senior official at the World Health Organisation (WHO) has said that Omicron is ‘highly unlikely’ to fully bypass vaccine protections.
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
